When a tumor stimulates the growth of new vessels, it is said to have undergone an 'angiogenic switch'.
Inhibiting angiogenesis requires treatment with anti-angiogenic factors, or drugs which reduce the production of pro-angiogenic factors, prevent them binding to their receptors or block their actions.